Reuters -- AstraZeneca Plc said on Wednesday it had appointed Martin Mackay from Pfizer Inc (PFE.N) as its global head of research and development, while Pfizer named Mikael Dolsten as its new R&D leader.
Reuters -- AstraZeneca Plc said on Wednesday it had appointed Martin Mackay from Pfizer Inc (PFE.N) as its global head of research and development, while Pfizer named Mikael Dolsten as its new R&D leader.
